Die Eckert & Ziegler Gruppe gehört zu den weltweit größten Anbietern von isotopentechnischen Komponenten für Strahlentherapie und Nuklearmedizin. Das Unternehmen hat seinen Sitz in Berlin.

COMPANY

Eckert & Ziegler

INVESTOR TERMSHEET

#BGFL app

#BGFL Publisher

EUZ

Eckert & Ziegler

#BGFL Mood: Neutral · #BGFL-Indicator: Hold · Review date: -

LEI: 391200EUDABLUKXCKG48

SECTOR: Gesundheit SUB-SECTOR: Medizintechnik

NAME

Eckert & Ziegler

WKN

565970

ISIN

DE0005659700

TICKER

EUZ

INDEX

SDAX

EXCHANGE

Xetra

BUY SELL

Made with ❤ von BGFL

#BGFL

Newswire

Ratings

#BGFL-nes Eckert & Ziegler: boersengefluester.de (BGFL) regularly writes extensive editorial articles for most of the companies in our database - especially those in the special stocks sector. Here we show you a list of the most recent articles by BGFL on the selected share.

16.05.2022	Eckert & Ziegler: Zurück auf Normal
08.07.2020	Eckert & Ziegler: So funktioniert das mit den Gratisaktien
31.07.2018	Eckert & Ziegler: Bahn frei für die Ü40
06.04.2018	Eckert & Ziegler: Einhörner dauern etwas länger
09.11.2017	Eckert & Ziegler: Bald kommt die Dividendenfrage

Newswire Eckert & Ziegler: Official company news is an enormously important source of information for investors - especially if it is particularly price-sensitive and therefore subject to ad hoc disclosure. Here we show the reports provided by the IR portal EQS News on companies from the BGFL coverage universe.

13.12.2024	EQS-News: Eckert & Ziegler Submits GalliaPharm® for Approval by Japan’s Health Authority MHLW
05.12.2024	EQS-News: Eckert & Ziegler and Ariceum Therapeutics Sign Global Supply Agreement for the Development of Next-Generation Radiotherapeutics for Precision Cancer Treatments
03.12.2024	EQS-News: Eckert & Ziegler: Changes in the Executive Board and Supervisory Board
02.12.2024	EQS-News: Eckert & Ziegler Begins Production of Actinium-225, Paving the Way for GMP-Grade Supply
27.11.2024	EQS-News: Eckert & Ziegler Achieves European Approval for Theralugand® - Lutetium-177 Chloride (n.c.a)

Resaerch for Eckert & Ziegler: Independent research is hard to find, especially in the speciality stocks sector. However, there are a number of firms that regularly produce meaningful analyses of the companies they cover. As a rule, this is paid research - but the analyses are definitely worth reading.

No data

The #BGFL Coverage App Gallery

Visualisation of financial information has been one of boersengefluester.de's (BGFL) favourite disciplines from the very beginning. For this reason, we also put a lot of effort into maintaining our own database and have developed numerous analysis tools and key figure tables on this basis.

Corporate Name Change

Financial Calendar

Interviews, Quotes, Analyses

IR-Quick Check

Annual Reports

Does news drive share prices or does the chain of effects run the other way round - as is often assumed? Well, at boersengefluester.de we offer you all kinds of ways to follow daily stock market events. Take a look at our apps on the subject of news.

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.

Eckert & Ziegler

Quick Links

Network

Partner

Contact

Eckert & Ziegler

Would you like to see fewer adverts? Simply register for a user account. Registration is free and significantly reduces the number of adverts.

Quick Links

Network

Partner

Contact